William (Bill) Grey

@billgrey.bsky.social

Group Leader, Leukaemia U.K. John Goldman Fellow, MRC CDA Fellow. We study proteostasis in healthy and malignant blood stem cells. www.proteostem.co.uk

Brian Huntly and I are looking to recruit a postdoc to investigate a promising novel therapeutic target in B-ALL @scicambridge.bsky.social. This new CRUK-funded project will involve collaboration with Prof Sir Steve Jackson's group @cruk-ci.bsky.social and the CRUK Functional Genomics centre.

Research Associate (Huntly Lab - Fixed Term)

We are seeking a postdoctoral Research Associate to work on an exciting new multi-disciplinary project studying B-cell acute lymphoblastic leukaemia (B-ALL). The project is a collaboration between Dr

cam.ac.uk

A decade of bold ideas, brilliant minds & real impact. 💡 Our John Goldman Fellowships are driving progress in leukaemia research, from identifying new drug targets to repurposing existing medicines. Read more: www.leukaemiauk.org.uk/stories/a-de...

A decade of progress and impact - Leukaemia UK

This October marks ten years since Leukaemia UK launched its John Goldman Fellowship (JGF) programme. In this blog, and the next, we’ll explore its impact and successes.

leukaemiauk.org.uk

Excited to share our collaborative work with Sheila Singh's lab: we performed an in vivo genome-wide CRISPRa screen using a lung TRACERx PDX model to uncover drivers of brain metastasis. BACE1 - already investigated as target in Alzheimer's - was as a key hit. www.science.org/doi/10.1126/...

A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis

Beta-secretase 1 promotes the spread of lung cancers to the brain through epidermal growth factor receptor signaling.

science.org

Following on from our recent paper showing novel post-transcriptional roles for B-catenin in leukaemia cells, a very well done to Drs Sevim & Park for writing a superb review in @natureportfolio.nature.com Oncogene summarising our current understanding of this field. www.nature.com/articles/s41...

Post-transcriptional control of gene expression by β-catenin: expanding the non-canonical ARMoury - Oncogene

Oncogene - Post-transcriptional control of gene expression by β-catenin: expanding the non-canonical ARMoury

nature.com

We're excited to see the launch of the TARGET study, co-led by @billgrey.bsky.social, to tackle AML relapse by targeting chemo-resistant stem cells. This could mean oral treatments at home, fewer side effects, and safer options for all. 🧡

Leeds Teaching Hospitals NHS Trust Research and Innovation@lthtresearchcomms.bsky.social · last yr.

A new research study @leedsth.nhs.uk and @york.ac.uk is set to transform treatments for one of the most aggressive and hard-to-treat blood cancers. Read ▶️ www.leedsth.nhs.uk/news/new-res... @leukaemiauk.bsky.social @bloodcanceruk.bsky.social @cbr-uoy.bsky.social

Excited to share our work - online today as a preprint. Here, we characterize precocious aging in HSCs of mice and people with sickle cell disease. Excitingly, we demonstrate the potential of senolytics to restore HSC function to the bone marrow of mice with SCD. www.biorxiv.org/content/10.1...

Senolytics Restore Hematopoietic Stem Cells Function in Sickle Cell Disease

Sickle Cell Disease (SCD) is a blood disorder affecting millions worldwide. Emerging evidence reveals that SCD pathophysiology increases risk of myeloid malignancies and hematopoietic stem cell (HSC) ...

biorxiv.org

Really enjoyed talking about the value of joining our community of scientists, working to solve the most difficult problems in hematopoiesis, HSPCs, leukemia and more. The International Society for Experimental Hematology welcomes burgeoning scientists and group leaders. Join! #ISEH #HSC #leukemia

ISEH - International Society for Experimental Hematology@isehsociety.bsky.social · 2y ago

Watch the latest interview with ISEH President @smckinneyfreeman.bsky.social on #SimplyBlood🩸 to hear more on ISEH benefits, advice for young investigators, and the future direction of ISEH and experimental hematology. www.simplyblood.org